Robert P Numerof

Summary

Affiliation: Bayer HealthCare
Country: USA

Publications

  1. ncbi request reprint 5th annual conference on cytokines and inflammation 29-30 January 2007, Breckenridge, Colorado, USA
    Robert P Numerof
    Inflammation and Immunology Therapeutic Research Group, Bayer HealthCare Pharmaceuticals, 2600 Hilltop Drive, PO Box 4099, Richmond, CA 94804 0099, USA
    Expert Opin Ther Targets 11:983-7. 2007
  2. ncbi request reprint Cytokines as potential therapeutic targets for inflammatory skin diseases
    Robert P Numerof
    RBA Dermatology USA, Berlex Biosciences, 2600 Hilltop Drive, PO Box 4099, Richmond, CA 94804 0099, USA
    Eur Cytokine Netw 16:101-3. 2005
  3. ncbi request reprint Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis
    Robert P Numerof
    Research Business Area Dermatology USA, Berlex Biosciences, Richmond, California 94804 0099, USA
    BioDrugs 20:93-103. 2006

Detail Information

Publications3

  1. ncbi request reprint 5th annual conference on cytokines and inflammation 29-30 January 2007, Breckenridge, Colorado, USA
    Robert P Numerof
    Inflammation and Immunology Therapeutic Research Group, Bayer HealthCare Pharmaceuticals, 2600 Hilltop Drive, PO Box 4099, Richmond, CA 94804 0099, USA
    Expert Opin Ther Targets 11:983-7. 2007
    ..This brief review summarizes key findings from the conference...
  2. ncbi request reprint Cytokines as potential therapeutic targets for inflammatory skin diseases
    Robert P Numerof
    RBA Dermatology USA, Berlex Biosciences, 2600 Hilltop Drive, PO Box 4099, Richmond, CA 94804 0099, USA
    Eur Cytokine Netw 16:101-3. 2005
    ..In this short review, we summarize key findings from a recent workshop on cytokines as potential therapeutic targets for inflammatory skin diseases...
  3. ncbi request reprint Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis
    Robert P Numerof
    Research Business Area Dermatology USA, Berlex Biosciences, Richmond, California 94804 0099, USA
    BioDrugs 20:93-103. 2006
    ....